arrow
E

Elsa Vitale

universitat de valencia
H指数:20
被引数:1,398

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Nutritional status and survival outcomes in patients with cancer treated with immune checkpoint inhibitors: The ARON-MOUSEION-20 systematic review and meta-analysis

免疫检查点抑制剂治疗癌症患者的营养状况与生存结局:ARON-MOUSEION-20系统评价与Meta分析

2026-09-300
PRE
Myositis in cancer patients receiving immune checkpoint inhibitors: the ARON-MOUSEION-017 systematic review and meta-analysis

接受免疫检查点抑制剂治疗的癌症患者中的肌炎:ARON-MOUSEION-017系统评价与荟萃分析

2026-08-140
PRE
Redefining breast cancer treatment by precision oncology: the clinical impact of sacituzumab govitecan

通过精准肿瘤学重新定义乳腺癌治疗:Sacituzumab Govitecan的临床影响

2026-01-010
PRE
Infusion-Related Reactions Among Cancer Patients Receiving Immune Checkpoint Inhibitors: The ARON-MOUSEION-013 Systematic Review and Meta-Analysis

免疫检查点抑制剂治疗癌症患者中的输注相关反应:ARON-MOUSEION-013系统评价与荟萃分析

2025-12-130
OA
Communicating bad news in oncology and hematology settings: A statistic and Large Language Model for interpreting nurses' difficulties and emotions

在肿瘤学和血液学环境中的坏消息沟通:用于解释护士困难与情绪的统计学和大型语言模型

2025-11-110
OAAI
Exploring Italians' knowledge of, and perceptions and feelings about stem cell donation: a GITMO-IBMDR nationwide survey
2025-11-011
PRE
Prognostic immunotherapy score (PIS) in patients with advanced urothelial carcinoma treated with pembrolizumab: real-world data and validation from ARON-2 dataset

预后免疫疗法评分(PIS)在经帕博利珠单抗治疗的晚期尿路上皮癌患者中的真实世界数据及ARON-2数据集验证

2025-09-060
PRE